Mipasetamab

Tax included
Mipasetamab is an IgG1κ antibody targeting to AXL, a tyrosine kinase receptor and an TAM Receptor. Mipasetamab involves in synthesis of ADCT-601 (Mipasetamab uzoptirine), an AXL-targeted antibody-drug conjugate (ADC). ADCT-601 has anti-tumor activity.
MedChemExpress 
HY-P99733

Data sheet

Size
Multiple sizes
Reactivity
TAM Receptor; ADC Antibody
Application
Cancer-Kinase/protease
CAS
2361055-48-1